Aqemia Secures $7.4M to Expand RNA-Targeting Programs With Physics-Based Generative AI
Aqemia has announced a $7.4 million grant from the France 2030 investment plan to accelerate its work in RNA-targeted drug …
News
Isomorphic Labs Raises $600M to Advance AI Drug Design and Internal Pipeline
Isomorphic Labs has secured $600 million in its first external funding round to accelerate the development of its AI-based drug …
Turn Bio Acquires Vesigen’s Microvesicle Delivery System for Epigenetic Therapies
Turn Biotechnologies, a biotechnology company based in Mountain View, California, announced on March 26, 2025, the acquisition of ARMMs (ARRDC1-Mediated …
seca Presents Real-Time Body Composition Tracker for GLP-1 Patients
seca, a global Hamburg-based medical measurement company founded in 1840, has introduced a new software platform called "Treatment Tracker," which …
Oxford Nanoimaging Launches ML-Driven Platform for Lipid Nanoparticle Characterization
Oxford Nanoimaging (ONI), founded in 2016 as a spin-out from the University of Oxford and headquartered in Oxford, UK, and …
A Call to Improve the UK Life Sciences Sector, Home to Over 6,800 Companies
In October 2024, the UK Government released an Industrial Strategy green paper outlining a 10-year plan for the sustainable economic …
Spatial Biology Company Alpenglow Biosciences Unveils 3D Imaging Interface for Light-Sheet Microscopy
Alpenglow Biosciences, a spatial biology company focused on 3D imaging, presented a new imaging interface, titled "LUMI", for light-sheet microscopy …
YC Startup ReactWise Raises $3.4M in Pre-Seed to Develop AI-Driven Robotic Labs for Drug Manufacturing
ReactWise, a UK-based startup developing AI-driven robotic laboratories for pharmaceutical and chemical manufacturing, has raised $3.4 million in pre-seed funding. …
Roivant Spinout Debuts AI Model to Combine Biomolecule Structure Prediction and Generation
VantAI, a NY-based spinout of Roivant founded in 2019, has introduced Neo-1, an artificial intelligence model that integrates atomic-level biomolecule …
23andMe Files for Bankruptcy
23andMe, the consumer genetics company, has filed for Chapter 11 bankruptcy protection and initiated a sale process. The filing comes …
Lilly-Backed Ampersand Raises $65M for Preclinical Immunology and Computational Drug Discovery
Ampersand Biomedicines has raised $65 million in a Series B funding round, with participation from Eli Lilly and Company and …
Microsoft and Inait to Develop Brain-Inspired AI for Finance and Robotics
Microsoft and Swiss startup Inait have announced a partnership to develop AI models inspired by mammalian brain function. Microsoft plans …